For this reason, many clinicians focus on monitoring response over time rather than assuming one dosing path works for everyone
Then, its time to choose your cuts
When used with insulin or sulfonylureas, dose adjustments of these medications may be needed to reduce hypoglycaemia risk
Over time, that steady output can wear on nearly every system, from the heart and gut to sleep and mood, as the American Psychological Association outlines in its review of how stress affects the body
Combining medications requires sterile compounding conditions
The American Diabetes Association Standards of Care recommend GLP-1 receptor agonists as second-line therapy for patients with established atherosclerotic cardiovascular disease or high cardiovascular risk, which strengthens the clinical rationale for coverage [4]